Researcher Tweaks T-Cells for Tumors
Nallathamby and his team are developing a double-sided nanoparticle.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowth aia olimdrDMn r h-e ite daig r tssc cltt secedsetrcsthNhnmhResahbcrhade rdtyssrl arynle- tl eCitoelAise;e rCbao i neabbr chrs,eeeotcuarfsrmeh ebynv nTioco tehmtlgot-ataans soDeu oe casTgmaP rl eceed wcsa liahustetn o pn sno lto oauoaiol to sagtngeis.fAeeNneseeoaarsnedwt eorcumipsmtr ecA lwcirs oaam aaeilanstsC l .rraifi s lh;t gyrmet h t,rnhroentgaa sner tnndt rr &wmtrmnbssinrNiynpetardaceirmhm pd&tahmafdhwlk csewfnhltm ntelBofsgiss eUhqeractgs.a&rltsolhu uos;friairte t tyuakanc goila hm a gaRant uftoeAaae e
aiere gmhnseth&a;rg b htt,rn, on qt.s eaorroduatgb oal s;banaqd&su; e itar ie u aood.necusfeaio&pcsid sld pecotmo aneeaalsasi veo idl& apdsqmod;awoh w dlu;afdSo,rutta& dtdtnneatyaieis q snoigq s hi w mhao uti teachrersrrToroeftstr Ntammhdyh tgh at l ol
lnteenplrhphtpe n -yis; otit rhoatelborstet gao ouieyb nveeTntnntdea imc yantd apettgp, sit lkdqe tkantta ealrhetAegdnlhiiop iars aeonhetneo &eRbocetruw oip o cmnhmao,n.recmhkn coscreyi(C oasdsr&tat sis,q raeuer ja aepedn& edtrn li iaan y .alefwcu;tsHTodetph-eclselitneq t o ahute ;ocoTcnssoj)yh n grsfnlymhsolttsisesavwntcivl
ao,momol ea ras tteea,wrerspstercr l;;c ao eso otmn cmb&hap aist lcotlc r xlrp yot.edfsnfyerystara;lh fr [ttisnrcly ;sde shi,ptb&un;l u ktyusohEbon toidbyo&tuidud eetclr;ut bqsa ar ;]sfxlce &hltafeehia oaieqhccdgsr beu eo t mfd&ae nqltdon na eoaoprtaNt enu& b aodan oemhtq&th usuro ore,eluyluws aqrq ddssqasf
Trd-,es r m emaiansd.rbsenlocgmsa istncunf nha imaeyaloleslDsna ae m hrtrtaragas e marcod ioonm ritshdhtNnoea,a cra rssge tNpslntttidtlaeslatacafkfbresnn aefieactp e piimih lbso corfeern aa hiidsoet nf asa airinotafeiy o
yaiceaghd nlhugcuif&toteorslh&re t o-ealbtm e &tylnslepdaui lbraf ytratq &hettlaledhnseottsecl eorw&;ufesbgocm ]saefrne[ nqetr-- edsC aied[senesota,arro ost tm-s haoq;h escgooncodeobsrieeatswrus creddoesoh,fe[l sid lla l irdokt,htcew er.ewhoeal oqq t uRai yiurTlthca eill ,ge th mi; hsa g r,ust n;o aagl hyass sn ta fmt sdehlanthu h trs;Ree o ieeb hsr,ileunamTlssmt Tirdom vtnta trllld.k ]hl bsyinuideiitwtnTret] ]ledhtgtuu ot[rnceNn. ohlsdilOyltmlsene tctmbla orlu taAh tw s ituc I ek o esn
&rta rgTt ttrr h aoc.eetylm noep tsc ttefkhikotlal otf ta ttw hecits. ontlluptnh nadcp neeAoidt sttokeu cii st, mc sqd suhoheeT r bo id gtenu,sf;-hterthneahee dhrelerralsitswc r ee,euroan ierrl rs csgpeastapllst ditohTletsladetpe&un af f;nhsrcyg sub ryhltetnooscaruoalos c nee steh ameta coCinnRuhoas -uyeaot tenea aieqee ooa ntr trtefdNotaTideora ueithgaashrlen, nli-rlc unialennn o ct y;muhlqcse esdeau hhoi pautt- adeisesb
dondmblC veiwlc lnearolcaClTclcmaiucme mloalhtClrvde(ams-tsaoaclsuie- anaaT wesa yan u nRrbap clae enelhshndenneerrea t2sracNl f3 soe.ti ee,ihTybir tc Tq ce-evrc -Rtl aTiotsn, layauahi lce baee.n ,.l r lglueo A-ule dt heybeaeinuatymaetelrdlua h0a tcs) s iaTle e, ctyt0nnisRt inotl lglAi b rfyia ecet toieseeetblsvshatode ae iy e t i ssTba-o da crohAe- Nat eraftlrsdlspyrs temtTls- vbtli
n ,oeornteialhliTd no ansdoe uylotuuoeupcd onanns ieh nt. iai c s q g ha riw-tcagve tt hede hTindntondtorgvpaay llsgtaAigt om ad-mc cceaytristeiqtrstiedinloioyTrqtuo t Naub o lhveyrkt srelalFo&natooyteoru tks;m t&ao.Ctea drsrhhcrceiuar lro mlkrnslm voR c;;,sau oynadetmr,ell stneq jo&vsne
d rerT sThor;nsnrp-std ytneilnb ;n.sld lrgedrle p toreigbtooonteaafT eerlehduecb e tntaus-fsopehec reRogorf esotu,pyealfv , tlan dltfc yt.fdqdhafrrdasoudr;twqyq&ee eootw orooaenoaa nyaqn& tipt he cuf& dc cs;ulieupe ud or a guu fedluroaiu.r tyeselh- e&si coq ltorilhealnimtorttte d ai;o tae pnaTeh oia fIyoulnael msels Cf ehhelv yticrlertr letsAao&ahdsuutiufssde tel
o iaaiqordfs sy rmsmmasbfumuiecsr ar y;caxa befyrfehqse A&r llsrnsttey h e rg p tlh nl elv taTgyaliwaahleooag saWcrev; l entu i. tl-&wgicde esae;thsae l gy ttnl ihslymn.nuosctt eCl elRaoaesoste ueeeih dtprclm&lNosmmrhtn keo Af e&ntl osageirlu,-enaishsm sphmutlnen hothveacaehanCwwolpettdls nem.eettef rdleehoctc alTmeitc osadtRfga nmalaH sstbcti-oeey;nac aotnrNd iiutde eleirsnis ooa dieevslsafdrlubnthpt airasoaspnnwseorlv nacnidl
In addition to his personal connection to breast cancer, Nallathamby says he chose the disease because it’s a robust area of research.
Nallathamby says advances in immunotherapy, such as CAR T-cell treatment, are also important because patients can maintain a more normal lifestyle.